Life Science Tools Market to 2035 - Strategic Developments & Key Insights
The global
life science tools market size was estimated at USD 167.82 billion in 2024
and is projected to reach USD 299.56 billion by 2030, growing at a CAGR of
10.21% from 2025 to 2030. This growth is primarily fueled by rising demand for
advanced research tools, increasing investments in pharmaceutical and
biotechnology R&D, and the expanding application of genomic technologies.
Artificial intelligence (AI) rapidly transforms the life
science tools industry, becoming integral to research and development
workflows. Organizations are increasingly leveraging AI to enhance data
analysis capabilities, streamline complex biological experiments, and
accelerate the discovery of novel therapeutics. Integrating AI with life
science tools allows researchers to process vast datasets generated from
genomics, proteomics, and metabolomics platforms with greater speed and
accuracy, significantly reducing the time from discovery to application.
Recent Development
• In January
2023, Agilent has acquired a company named Avida Biomed. The acquisition is
expected to drive the market reach for clinical research and diagnostics
markets.
• In March
2023, Apollo introduced its next-generation market insights technology platform
with the goal of enabling rapid data collection and insights in the life
science and Biopharmaceutical Company industries. Apollo is a well-known source
provider of real-time global data and insights for life science &
Biopharmaceutical Company sectors. The increasing artificial intelligence (AI)
and machine learning (ML) platforms are contribution for the investments in its
core technologies.

Comments
Post a Comment